Unlocking Asthma Remission: Key Insights from an Expert Roundtable Discussion

<bold>Background:</bold> Treatment targets in severe asthma have evolved towards a remission-focused paradigm guided by precision medicine. However, the concept is still emerging. <bold>Objective:</bold> To understand the strengths, weaknesses, confounders, application and future of the current construct of asthma remission. <bold>Methods:</bold> A hybrid face-to-face and virtual roundtable discussion was held on the 30th of April 2024. The summary of discussions is narratively synthesised. <bold>Results:</bold> The participants (n=27 international asthma experts) observed that between one in three to one in five people treated with biologics/macrolides experience low disease activity over a sustained period. Labelling the attained clinical state as clinical remission is useful as a clinical, policy and scientific tool. Current remission rates vary significantly due to definition variability. The minimum requirements of asthma remission have been proposed. When assessing remission, it is essential to consider confounding factors. More research is required to reach an acceptable definition, and including the patient's voice in such research is essential. The themes discussed and the suggestions are summarised in Figure 1. <bold>Conclusion:</bold> The concept of treatment-induced clinical remission is possible and valuable in asthma. However, further refinement of the definition is required. <fig><object-id>erj;66/suppl_69/PA3651/F1</object-id><object-id>F1</object-id><object-id>F1</object-id><graphic></graphic></fig>

Authors

Institutions

Publication Details

Published
2025-09-27
DOI
https://doi.org/10.1183/13993003.congress-2025.pa3651
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Unlocking Asthma Remission: Key Insights from an Expert Roundtable Discussion

Kirsty Murray, Eleanor Majellano, Matthew Peters, Gary P. Anderson et al.
Asthma and respiratory diseases
article

Unlocking Asthma Remission: Key Insights from an Expert Roundtable Discussion

Kirsty Murray, Eleanor Majellano, Matthew Peters, Gary P. Anderson, Constance H. Katelaris, John Harrington, Vanessa Clark, Anne E. Holland, Peter A. B. Wark, Philip G. Bardin, John W. Upham, Claude S. Farah, Peter G. Gibson, Katrina O. Tonga, Jimmy Chien, Christine Jenkins, Dennis Thomas, Gregory Katsoulotos, Hayley Lewthwaite, Richard Beasley, Vanessa M. McDonald, Michael Fricker, Erin S. Harvey, Mark Hew, Vibeke Backer, Yuto Hamada, R. L. Thomas
article en

Abstract

<bold>Background:</bold> Treatment targets in severe asthma have evolved towards a remission-focused paradigm guided by precision medicine. However, the concept is still emerging. <bold>Objective:</bold> To understand the strengths, weaknesses, confounders, application and future of the current construct of asthma remission. <bold>Methods:</bold> A hybrid face-to-face and virtual roundtable discussion was held on the 30th of April 2024. The summary of discussions is narratively synthesised. <bold>Results:</bold> The participants (n=27 international asthma experts) observed that between one in three to one in five people treated with biologics/macrolides experience low disease activity over a sustained period. Labelling the attained clinical state as clinical remission is useful as a clinical, policy and scientific tool. Current remission rates vary significantly due to definition variability. The minimum requirements of asthma remission have been proposed. When assessing remission, it is essential to consider confounding factors. More research is required to reach an acceptable definition, and including the patient's voice in such research is essential. The themes discussed and the suggestions are summarised in Figure 1. <bold>Conclusion:</bold> The concept of treatment-induced clinical remission is possible and valuable in asthma. However, further refinement of the definition is required. <fig><object-id>erj;66/suppl_69/PA3651/F1</object-id><object-id>F1</object-id><object-id>F1</object-id><graphic></graphic></fig>

Camden and Campbelltown Hospitals (AU), Concord Hospital (US), The University of Melbourne (AU), Concord Repatriation General Hospital (AU), John Hunter Hospital (AU), Princess Alexandra Hospital (AU), The Alfred Hospital (AU), Copenhagen University Hospital (DK), Hudson Institute of Medical Research (AU), Rigshospitalet (DK), Westmead Hospital (AU), Hunter Medical Research Institute (AU), National Sagamihara Hospital (JP), Monash Health (AU), St Vincent's Clinic (AU), Medical Research Institute of New Zealand (NZ), Melbourne Health (AU), Alfred Health (AU), Monash University (AU), The University of Notre Dame Australia (AU), Macquarie University (AU)
Openalex Percentile: Top 55%
Asthma and respiratory diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.